IDF21-0484 Case cohort, Observational Study to assess Safety and effectiveness of rEmogliflozin in T2DM-CASE study

Autor: Kavathiya, K., Korukonda, K.
Zdroj: In Diabetes Research and Clinical Practice April 2022 186 Supplement 1
Databáze: ScienceDirect